Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease

Journal of Human Hypertension

Volumn 25, Issue 3, 2011, Pages 144-151

  Nardi, E ^a   Palermo, A ^a   Mule G ^a   Cusimano, P ^a   Cottone, S ^a   Cerasola, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

chronic kidney disease; diabetes; diastolic dysfunction; heart diseases; left ventricular hypertrophy

Indexed keywords

ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; TISSUE DOPPLER IMAGING;

AGED; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; VENTRICULAR REMODELING;

EID: 79951674458     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.96     Document Type: Article

References (35)

1. Nardi E, Palermo A, Mulè G, Cusimano P, Cottone S, Cerasola G. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 2009; 27: 633-641.
2. Henry RM, Kamp O, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G et al. Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: an arterial stiffness-related pheno-menon-The Hoorn Study. Kidney Int 2005; 68: 673-679. (Pubitemid 43323122)
3. Paoletti E, Bellino D, Casottana P, Rolla D, Cannella G. Left ventricular hypertrophy in nondiabetic predialy-sis CKD. Am J Kidney Dis 2005; 46: 320-327. (Pubitemid 41040362)
4. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barré PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-2031.
5. Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis 2002; 40: 1202-1210. (Pubitemid 35403132)
6. Fathi R, Isbel N, Haluska B, Case C, Johnson DW, Marwick TH. Correlates of subclinical left ventricular dysfunction in ESRD. Am J Kidney Dis 2003; 41: 1016-1025. (Pubitemid 36532136)
7. Nardi E, Cottone S, Mulè G, Palermo A, Cusimano P, Cerasola G. Influence of chronic renal insufficiency on left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Nephrol 2007; 20: 320-328. (Pubitemid 47570362)
8. Miyazato J, Horio T, Takiuchi S, Kamide K, Sasaki O, Nakamura S et al. Left ventricular diastolic dysfunction in patients with chronic renal failure: impact of diabetes mellitus. Diabet Med 2005; 22: 730-736. (Pubitemid 40805894)
9. Centers for Disease Control and Prevention (CDC). Prevalence of Chronic Kidney Disease and Associated Risk Factors-United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007; 56: 161-165.
10. Kannell WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2: 120-126. (Pubitemid 9238733)
11. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134-1146. (Pubitemid 29416243)
12. Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234. (Pubitemid 28350165)
13. Liu JE, Palmieri V, Roman MJ, Bella JN, Fabsitz R, Howard BV et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 2001; 37: 1943-1949. (Pubitemid 32499984)
14. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187. (Pubitemid 46924065)
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-S266.
17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
19. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardio-graphy: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1073.
20. Lester SJ, Tajik AJ, Nishimura RA, Khandheria BK, Seward JB. Unlocking the mysteries of diastolic function. J Am Coll Cardiol 2008; 51: 679-689.
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458. (Pubitemid 16119719)
22. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and the impact of overweight. J Am Coll Cardiol 1992; 20: 1251-1260.
23. Schiller N, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocar-diograms. J Am Soc Echocardiogr 1989; 2: 358-367.
24. Shan K, Bick RJ, Poindexter BJ, Shimoni S, Letsou GV, Reardon MJ et al. Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. J Am Coll Cardiol 2000; 36: 891-896.
25. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30: 474-480.
26. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000; 102: 1788-1794.
27. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK et al. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 2000; 101: 2271-2276. (Pubitemid 30317129)
28. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY et al. Effect of type 2 diabetes on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGen) study. Circulation 2001; 103: 102-107. (Pubitemid 32050443)
29. Gerdts E, Okin PM, Omvik P, Watchell K, Dahlof B, Hildebrandt P et al. Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study. Nutr Metab Cardiovasc Dis 2009; 19: 306-312.
30. van Hoeven KH, Factor SM. A comparison of the pathological spectrum of hypertensive, diabetci, and hypertensive-diabetic heart disease. Circulation 1990; 82: 848-855. (Pubitemid 20316736)
31. Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 1990; 5: 39-44. (Pubitemid 20105635)
32. Amann K, Breitbach M, Ritz E, Mall G. Myocyte/ capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998; 9: 1018-1022.
33. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820. (Pubitemid 34000785)
34. Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildeb-randt P, Mehlsen J et al. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care 1999; 22: 1186-1190. (Pubitemid 29293975)
35. Bezante GP, Viazzi F, Leoncini G, Ratto E, Conti N, Balbi M et al. Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage. Am J Hypertens 2009; 22: 191-196.